Current pacemaker and defibrillator therapy.
نویسندگان
چکیده
BACKGROUND Pacemakers have been available for 50 years, and implantable cardiac defibrillators for 25. Clear indications for each have been established on the basis of data from randomized clinical trials (RCTs). METHODS This review article is the product of a collaborative effort by a cardiologist and a cardiac surgeon. The authors arrived at a consensus through a selective review of the literature, with special attention to randomized controlled trials and registry data. RESULTS Atrioventricular (AV) block only rarely necessitates permanent pacemaker stimulation after inferior myocardial infarction, of which it is a rare (12% to 20%) and often transient accompaniment. AV block is more common, however, in anterior wall infarction (frequency ca. 5%), and often necessitates permanent pacemaker therapy in such cases. Pacemaker complications are rare; they include oversensing (the detection of impulse noise) (0.7%), undersensing (the failure to detect impulses) (3.8%), electrode fractures (3.8%), isolation defects (3.4%), perforation (<1%), dislocation (<1%), and infection (<1% to 12%). Many RCTs have confirmed that defibrillators are effective in the prevention of sudden cardiac death (SCD): they lower the risk of SCD by 20% to 30% in primary prevention and by 20% to 40% in secondary prevention. Cardiac resynchronization therapy improves the clinical manifestations and outcome of patients with congestive heart failure, with a relative risk reduction (RR) of 20% to 40%, even among patients in NYHA classes I and II (RR ca. 40%). Implantable defibrillators only rarely cause problems or complications in either the short or the long term. Emotional disturbances, including anxiety, are a rare side effect, occurring in less than 1% of cases. CONCLUSION Pacemakers and implantable defibrillators are well-established electrotherapeutic devices that are highly effective and have only rare complications.
منابع مشابه
Comparison of the effect of training by video and group discussion on the level of stress, anxiety, depression and self-efficacy of patients undergoing pacemaker and cardiac implantation defibrillator
متن کامل
Pacemaker lead endocarditis with hiccups (Kalayci)
Background: Lead-related infections that might develop after pacemaker implantation associated with high mortality and morbidity rates are challenging to manage and pose high-cost. Patients with lead-related infections usually present with fever, chills and fatigue and the treatment can be challenging unless the implant system is extracted. Case presentation: A 66-year old male patient who und...
متن کاملIs correction for metallic artefacts mandatory in cardiac SPECT/CT imaging in the presence of pacemaker and implantable cardioverter defibrillator leads?
Introduction: Metallic artifacts due to pacemaker/ implantable cardioverter defibrillator (ICD) leads in CT images can produce artifactual uptake in cardiac SPECT/CT images. The aim of this study was to determine the influence of the metallic artifacts due to pacemaker and ICD leads on myocardial SPECT/CT imaging. Methods: The study included 9 patients wh...
متن کاملCardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
BACKGROUND We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS A total of 1520 patients who had advanced heart failure (New York H...
متن کاملThe influence of neutron contamination on pacemaker in photon beam radiotherapy by LINAC using the Monte Carlo method
In radiation therapy with high-energy photon beams (E > 10 MV) neutrons are generated mainly in LINACs head thorough (γ,n) interactions. These neutrons affect the shielding requirements in radiation therapy rooms. According to the AAPMTG-34 report, photon absorbed dose of 10Gy can cause permanent damage to the pacemaker and the dose of 2Gy can make minor changes in the functioning of the pac...
متن کاملLong-Term Follow-Up of Patients With Long-QT Syndrome Treated With b-Blockers and Continuous Pacing
Background—The long-QT syndrome is associated with sudden cardiac death. Combination of b-blocker and pacing therapy has been proposed for treatment of drug-resistant patients. The purpose of this study was to summarize our long-term experience with combined therapy in patients with long-QT syndrome. Methods and Results—A total of 37 patients with idiopathic long-QT syndrome were treated with c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Deutsches Arzteblatt international
دوره 108 21 شماره
صفحات -
تاریخ انتشار 2011